IHPI

IHPI, the Ibogaine Healthcare Policy Institute, is a U.S.-based 501(c)(3) nonprofit focused on policy infrastructure for regulated ibogaine care. Its stated audience includes healthcare decision-makers such as CMS, Medicaid leaders, commercial payers, regulators, and health system executives. The organization says it provides neutral, decision-grade resources on safety, payment, and implementation for ibogaine treatment.

IHPI frames its role as building the legal and operational infrastructure needed for regulated ibogaine treatment in the United States, with an emphasis on veterans and people affected by PTSD and opioid use disorder. Its work includes regulatory pathways, safety and delivery standards, and payer system infrastructure such as reimbursement mechanics, coding roadmaps, budget impact logic, and coverage criteria. A published April 2026 explainer indicates it is actively interpreting federal psychedelic policy for downstream implementation, coverage, and delivery questions.